Connection
Laura Pyle to RNAi Therapeutics
This is a "connection" page, showing publications Laura Pyle has written about RNAi Therapeutics.
|
|
Connection Strength |
|
|
|
|
|
0.830 |
|
|
|
-
Shah VN, Pyle L. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med. 2021 11 11; 385(20):e69.
Score: 0.830